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Abstract 
A possible interaction between tumor necrosis factor-or (TNF) and other cytokines/growth factors in stimulating the production of nerve growth 
factor (NGF) in Swiss 3T3 cells was studied. TNF’s stimulatory activity on fibroblast NGF production was synergized by interleukin-la (IL-la), 
IL-ID and interferon-y (IFN-y), but was antagonized by transforming rowth factor-p (TGF-p). The most remarkable synergistic effect was observed 
between TNF and IL-la@; as little as 0.003 ng/ml of IL-lb markedly enhanced TNF’s stimulatory activity on NGF production in the cells. These 
findings reinforce the idea that TNF, in concert with IL-lu@, plays an essential role in regulating the regeneration of peripheral nerves following 
injury through an indirect mechanism by which it stimulates NGF production in fibroblasts. 
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1. Introduction 
Tumor necrosis factor-a (TNF), a macrophage/mon- 
ocyte-derived cytokine, was originally identified as a fac- 
tor with anti-tumor activity in vitro and in vivo, but is 
now known to be implicated in diverse biological proc- 
esses including inflammation, immunoregulation, anti- 
viral defense, endotoxic shock, cachexia, angiogenesis, 
and mitogenesis (reviewed in [l]). Synergistic and/or an- 
tagonistic interactions of TNF with other cytokines in 
eliciting such a wide spectrum of biological activities 
have been reported. For example, the anti-proliferative 
activity of TNF on some tumor cells is synergized by 
IFN-y [2] and IL-l [3], or is antagonized by TGF-cx and 
TGF-p [4]; antiviral activity of TNF is synergized with 
sub-effective concentrations of IFN-B [5]; growth-pro- 
moting action of TNF on fibroblasts is synergized by 
epidermal growth factor (EGF), platelet-derived growth 
factor (PDGF), basic fibroblast growth factor (bFGF) 
and TGF-/?, or is inhibited by IFN-/? and -y [6]. 
We have recently shown that TNF is also involved in 
modulating neuronal cell function through an indirect 
mechanism by which it stimulates the synthesis and se- 
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cretion of NGF in fibroblasts and glial cells [7]. Here we 
have asked whether or not this newly found action of 
TNF is influenced by the presence of other cytokines/ 
growth factors. 
2. Materials and methods 
2. I. Cell culture 
Swiss albino mouse fibroblasts (3T3 cells; American Type Culture 
Collection, CCL92) was obtained through the Japanese Cancer Re- 
search Resources Bank. Subconfluent cultures of Swiss 3T3 cells in 
Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal 
calf serum were rendered quiescent by incubation in serum-free medium 
(DMEM containing 5 mg/ml of bovine serum albumin, 10 @ml soy 
bean lipid, 1 &ml insulin, 2puglml transferin, 20 nM Na,SeO,, and 10 
mM HEPES, pH 7.4) for 24 h; TNF and/or other cytokines/growth 
factors were then added [7]. 
2.2. Two-site enzyme immunoassay of NGF 
NGF contents in the conditioned media of Swiss 3T3 cells, treated 
with TNF and/or other cytokines for 48 h, were assayed by the two-site 
enzyme immunoassay (EIA) specific for mouse submaxillary gland 
p-NGF [8]. Before the assay, each conditioned medium was passed 
through a 0.22~pm filter to remove cell debris. 
2.3. Materials 
Recombinant human TNF-a was produced in Escherichia coli and 
purified to homogeniety as described previously [9]. Recombinant 
human IL-la, -lp, recombinant human PDGF (BB homodimer), re- 
combinant human bFGF and recombinant human EGF were pur- 
chased from Toyobo (Osaka), recombinant mouse IFN-y was from 
Genzyme (Cambridge), and recombinant human TGF-B was from 
Wako Pure Chemical Industries Ltd. (Osaka). Other chemicals and 
reagents were of the purest grade available. 
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3. Results 
As combinations of cytokines have been reported to 
act synergistically to produce a variety of effects in many 
cell systems, we examined whether or not TNF’s stimula- 
tory activity on NGF production in fibroblasts [7] is 
influenced by the presence of other cytokines/growth fac- 
tors. TNF, IL-la, IL-l/?, EGF, bFGF, IFN-y, and 
TGF-/I by themselves stimulated the production of NGF 
in Swiss 3T3 cells, although to varying degrees, TNF 
being the most potent (Table 1). Combinations of TNF 
and EGF or bFGF showed that paired factors had 
roughly additive effects on fibroblast NGF production, 
which was also the case with the combinations of IL-l/I 
and bFGF, EGF (data not shown) or IFN-y. On the 
contrary, simultaneous addition of TNF and IL-la, IL- 
l/3 or IFN-y stimulated the production of NGF in Swiss 
3T3 cells to much greater degrees than did each agent 
alone; these effects were apparently synergistic since the 
amount of NGF produced by the cells incubated in TNF 
plus IL-la, TNF plus IL-@ or TNF plus IFN-y ex- 
ceeded the sum of the NGF produced by fibroblasts 
incubated with the cytokines separately (Table 1). Al- 
though TGF-p by itself stimulated the production of 
NGF in Swiss 3T3 cells, it rather antagonized the stimu- 
latory effects of TNF and IL-l/3 on fibroblast NGF pro- 
duction when used in combination. 
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Next we examined the optimal concentrations of com- 
binations of TNF, IL-l and IFN-)I that stimulate the 
NGF production in Swiss 3T3 cells. As shown in Fig. 1, 
each cytokine stimulated the production of NGF in the 
cells in a dose-dependent manner with a maximum being 
noted with - 10 ng/ml of TNF, - 1 rig/ml of IL-j?, and - 10 
U/ml of IFN-y. Stimulatory effects of IL-1s and IFN-y 
on fibroblast NGF production were markedly enhanced 
by the presence of TNF at concentrations greater than 
3 ng/ml (Fig. lA), and that of TNF was synergistically 
increased by IFN-y at concentrations greater than 3 U/ 
ml (Fig. 1B). The most remarkable synergistic effect on 
the stimulation of NGF production in the cells was ob- 
served between IL-l and TNF. As shown in Fig. lC, as 
little as 0.003 ng/ml of IL-l/3 and IL-la (data not shown) 
apparently synergized TNF’s stimulatory activity on 
NGF production in Swiss 3T3 cells, which was maximal 
at a concentration of -1 rig/ml. 
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The timecourse of stimulation of the fibroblast NGF 
production by combinations of TNF, IL-l/I, IFN-y and 
bFGF was examined. We have previously shown that the 
stimulation of NGF production in TNF-treated Swiss 
3T3 cells is a result of an increase in the NGF mRNA 
level [7]. It is, however, rather a late response of cells; the 
increase in the NGF mRNA level is detectable only after 
6 h, and is maximal by 12-18 h of incubation with TNF. 
Accordingly, the increase in the NGF protein concentra- 
tion in the culture medium of TNF-treated cells was 
observed with a lag time of - 12 h; this was also the case 
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Fig. 1. Dose-dependence of combinations of TNF, IL-IS, and IFN-y 
that stimulate the NGF production in Swiss 3T3 cells. Swiss 3T3 cells 
were cultured with varying doses of TNF (A), IFN-y (B), or IL-l/I (C) 
with or without TNF (30 &ml), IFN-y (30 U/ml), or IL-lb (3 &ml) 
for 48 h, and then NGF content in the culture media were assayed by 
EIA. In this experiment, NGF concentration was not normalized to cell 
number at the end of culture: TNF, IL-l/I and IFN-)I were weak 
mitogens for Swiss 3T3 cells, and the cell numbers after a 48-h treat- 
ment with these cytokines (used separately or m combination) were 
lOO-121% of unstimulated control. Means f S.E.M. of 8 determina- 
tions using two 35cm dishes for each experimental condition are indi- 
cated. Data shown are representative of three experiments that gave 
essentially the same results. 
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in cells treated with IL-1s (Fig. 2A). In contrast, bFGF 
induced a more rapid stimulation of the fibroblast NGF 
production, which was maximal by 12 h. Such a rapid 
stimulation of NGF production in acidic FGF-treated 
astorocytes has been reported previously [lo]. The mark- 
edly synergistic effect of the combination of TNF and 
IL-l/? or IFN-y on the NGF production in Swiss 3T3 
cells was apparent after 24 h; even when used in combi- 
nation, these cytokines did not elicit a more rapid pro- 
duction of NGF in the cells than did bFGF (Fig. 2B). 
Simultaneous addition of TNF and bFGF showed only 
an additive effect on the fibroblast NGF production at 
any op the time points examined. 
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4. Discussion 
The present study has clearly shown that TNF’s stim- 
ulatory activity on NGF production in fibroblasts we 
found recently [7] is synergized by IL-la, -/? and IFN-)I, 
and is antagonized by TGF-/3. Similar synergistic and/or 
antagonistic interactions of TNF with various cytokines 
Table 1 
Stimulation of NGF production in Swiss 3T3 cells by various cytokines/ 
growth factors 
Treatment NGF 
production” 
(fg/cell/48 h) 
Fold 0 12 24 36 
Time (h) 
Control 0.570 f 0.051 1.00 
TNF (30 @ml) 3.101 It: 0.138 5.44 
IL-la (3 @ml) 1.374 f 0.162 2.41 
IL-IS (3 ng/ml) 1.260 z!z 0.073 2.21 
IFN-)I (30 U/ml) 0.770 f 0.040 1.35 
bFGF (5 &ml) 1.436 f 0.223 2.52 
EGF (10 @ml) 0.638 f 0.114 1.12 
TGF-/I (3 @ml) 1.357 + 0.179 2.38 
TNF (30 @ml) + IL-la (3 @ml) 13.395 f 1.921 23.50 (6.85)b 
+ IL-1s (3 rig/ml) 13.076 f 0.711 22.94 (6.65) 
+ IFN-y (30 U/ml) 6.766 + 0.255 11.87 (5.79) 
+ bFGF (5 @ml) 4.680 f. 0.140 8.21 (6.96) 
+ EGF (10 &ml) 2.662 f 0.333 4.67 (5.56) 
+ TGF-/.I (5 ng/ml) 2.177 f 0.105 3.82 (6.82) 
Fig. 2. Time-dependent increase of NGF production in Swiss 3T3 cells 
by various cytokines/growth factors. NGF content in the culture media 
of Swiss 3T3 cells treated for varying times with each cytokine/growth 
factor separately (A), or in combination (B), were assayed by EIA. In 
this experiment, NGF concentration was not normalized to cell number 
at the end of culture: unlike TNF, IL-lb and IFN-y, bFGF strongly 
stimulated cell proliferation and cell numbers after a 48-h treatment 
with bFGF was 184% and that with bFGF/TNF was 174% of unstim- 
ulated control. MeansfS.E.M. of 8 determinations using 2 dishes for 
each experimental condition are indicated. Data shown are representa- 
tive of three experiments that gave essentially the same results. 
IL-1s (3 &ml) + IFN-y (30 U/ml) 1.676 f 0.295 2.94 (2.50) 
+ bFGF (5 &ml) 2.234 f 0.421 3.92 (3.73) 
+ TGF-/3 (5 @ml) 1.043 f 0.177 1.83 (3.59) 
in eliciting its other wide spectrum of biological activities 
have been reported [2-&l 11. 
“NGF content in the culture medium of Swiss 3T3 cells treated with 
various cytokines/growth factors for 48 h was assayed by EIA and then 
normalized with respect o cell numbers at the end of culture [7]. Values 
are expressed as the means f S.E.M. of 8 determinations using 2 dishes 
for each experimental condition. The amount of NGF produced by the 
cells varied to some extent from one experiment to another (0.4550.87 
fg of NGF/celY48 h for unstimulated cells), but the stimulatory effect 
of these growth factors (used separately or in combination) on NGF 
production was essentially identical in six separate xperiments. 
bValues for the sum of NGF produced by Swiss 3T3 cells incubated 
with the cytokines separately are in parentheses. 
The most remarkable synergistic effect on NGF pro- 
duction in Swiss 3T3 cells is observed between TNF and 
IL-lo@; as little as 0.003 @ml of IL-1s markedly en- 
hances the TNF’s stimulatory activity on NGF produc- 
tion in the cells (Fig. 1C). This observation sounds very 
interesting because (i) it has been suggested that the mac- 
rophage-dependent process of Wallerian degeneration is 
a necessary prologue for peripheral sensory nerve regen- 
eration [12], (ii) macrophages invading the site of nerve 
lesion during Wallerian degeneration have been shown 
to be important in the regulation of NGF synthesis [13], 
and (iii) TNF, IL-la and IL-l/I are the major inflamma- 
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tory cytokines characteristically produced at the site of 
inflammation by macrophages/monocytes [l 11. Consid- 
ering all this, it seems very likely that TNF, in concert 
with IL-la//?, plays an essential role in regulating the 
regeneration of peripheral nerves following injury 
through an indirect mechanism by which it stimulates 
NGF production in fibroblasts. 
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